Following the successful ESCP2021 workshop on single cell proteomics sample preparation, we will be holding a re-stream event ASCP2021 on the 17th of June 2021. […]

Cellenion and ECOBIO laboratory (UMR CNRS-University of Rennes) have received a Labcom-2020 €360k grant by the French National Research Agency (ANR) for the creation of […]

CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the owners of Scienion AG (“Scienion”), a German life science company focusing on precision dispensing technologies, to acquire all shares for a purchase price on cash- and debt-free basis of 80 M euros (the “Acquisition”). 40 M euros will be paid in 2,814,032 newly issued shares of series B in CELLINK (the “Consideration Shares”) and the reminder in cash. CELLINK’s Board of Directors will resolve to issue the Consideration Shares in accordance with the authorization from the Annual General Meeting held on December 18, 2019.
CELLINK also contemplates to explore the conditions for raising additional equity through one directed share issue within the limit of CELLINK’s existing authorization to issue shares from the Extraordinary General Meeting held on July 16, 2020.

RareCyte utilizes cellenONE to benchmark and optimize the performance of their proprietary liquid biopsy technology platform

The safety of our employees, customers, families and visitors remains CELLENION’s first priority. As the coronavirus disease 2019 (COVID-19) outbreak continues to evolve and spreads […]

cellenion«s innovative technology has been presented and published at transkript, a leading German-speaking news magazine for biotechnology and life sciences.

Visit us at MEDICA and discover our sciDROP PICO and NANO together in our sciFLEXARRAYER SX. News about cellenion: Single cell Whole Genome Sequencing study […]

SCIENION wishes you a Merry Christmas and a Happy New Year. Please be aware that due to Christmas vacations SCIENION AG and CELLENION SASU offices […]

Single cell isolation can be easy and reliable with the right choice of technology

Combined use of MACSQuant® Tyto® Cell Sorter and cellenONE® X1 single-cell deposition unit allows for time- and cost-efficient production of high-expressing and fast-expanding monoclonal cell lines.